1939 was founded in Shanxi.
1949 moved from Shanxi to Beijing to establish Beijing Chemical Pharmaceutical Factory. 1964 changed its name to Beijing Pharmaceutical Factory.
Beijing Pharmaceutical Corporation was established on 1979. Beijing is a municipal pharmaceutical industrial company, a municipal medical device industrial company, a municipal medicinal material company and a municipal pharmaceutical company.
Including the whole system of the company and the municipal medical procurement and supply station.
1995 Beijing pharmaceutical corporation was awarded the right to operate state-owned assets.
1996 authorized Beijing pharmaceutical corporation to perform the administrative functions of Beijing pharmaceutical industry, and added the brand of Beijing pharmaceutical administration.
1997 Beijing Shuanghe pharmaceutical co., ltd and Beijing wandong medical device co., ltd are listed on the Shanghai stock exchange.
1998 Beijing pharmaceutical corporation was restructured into a wholly state-owned company-Beijing pharmaceutical group co., ltd.
In 2000, the government and enterprises were separated, and the administrative functions of Beijing pharmaceutical industry were no longer performed.
In 2002, Beijing Pharmaceutical Group Co., Ltd. was authorized to exercise investor power over the state-owned assets of its wholly-owned enterprises and shareholding enterprises.
In 2004, Beijing Pharmaceutical Group Co., Ltd. successfully introduced strategic investors and became a diversified equity enterprise.
In 2005, the Natural Medicine Division and Prescription Medicine Division of Beijing Pharmaceutical Group Co., Ltd. were established, and the sales revenue of the group exceeded 654.38+0 billion for the first time.
Yuan, ranked fourth among the top 500 pharmaceutical enterprises in China.
In 2006, Beijing Pharmaceutical Group Co., Ltd. achieved sales revenue of 654.38+074 billion yuan, ranking third among the national pharmaceutical enterprises.
In 2007, Beijing Pharmaceutical Group Co., Ltd. achieved sales revenue of 20.45 billion yuan. Wei Huacheng, Chairman and Party Secretary of the Group, gave a report entitled "Conspiring for Great Development and Rebuilding New North Medicine". The report reviewed the Group's transformation practice and summarized five successful experiences, namely: holding high the banner of strategy leading; Vigorously carry out resource integration, focus and professional development; Strengthen the construction of comprehensive budget, authorized operation and performance appraisal mechanism; Strengthen the basic management of market orientation; Do a good job in personnel training and corporate culture construction. The report comprehensively analyzes the situation and tasks, summarizes the development gap of the group, and points out that the next three years will be a crucial period for the development of North Pharmaceutical Group. We should strive to build a passionate North Pharmaceutical, innovate North Pharmaceutical, develop North Pharmaceutical, harmonize North Pharmaceutical, and recreate a new North Pharmaceutical at a new starting point. He Xuan, the general manager of the group, gave a report entitled "Make great efforts, be pragmatic and innovative, and play a good game of chess to achieve new goals". On the basis of summarizing all the work in 2007, the report points out that it is necessary to carry out three tasks in depth, accelerate four processes, and play a good game to achieve new goals, that is, to implement business strategy in depth and improve the level of comprehensive budget management. Carry out in-depth marketing innovation to improve product sales ability; Carry out refined management in depth to improve profitability; Accelerate the transformation of economic development mode and promote the process of industrial structure optimization and upgrading; Accelerate the process of resource integration and realize the leap-forward development of enterprises; Speed up the process of product research and development and improve the sustainable development ability of enterprises; Accelerate the process of corporate culture construction and improve the overall organizational efficiency of the group; Go all out to ensure a good environment for the Olympic Games.
The leaders delivered warm speeches, fully affirmed the rapid development of Beijing Pharmaceutical Group, and put forward higher requirements for future development. Sasac director Xiong Daxin pointed out in his speech that the successful practice of the restructuring of Beijing Pharmaceutical Group benefited from the mechanism and system innovation brought by the restructuring, the clear development strategy guidance and the excellent team of Beijing Pharmaceutical Group. I hope that Beijing Pharmaceutical Group can sum up its experience, innovate constantly and create greater glories. The blueprint has been drawn and the horn has sounded. With dreams and passions, the people of Beiyao will plan and develop with a higher vision and a higher starting point, measure their work with a higher standard, and constantly promote the new development of the group company with a more conscious attitude and more powerful measures, so as to recreate a thriving New North Medicine in the next three years.